Your browser doesn't support javascript.
loading
Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial.
Lee, I Russel; Tong, Steven Y C; Davis, Joshua S; Paterson, David L; Syed-Omar, Sharifah F; Peck, Kwong Ran; Chung, Doo Ryeon; Cooke, Graham S; Libau, Eshele Anak; Rahman, Siti-Nabilah B A; Gandhi, Mihir P; Shi, Luming; Zheng, Shuwei; Chaung, Jenna; Tan, Seow Yen; Kalimuddin, Shirin; Archuleta, Sophia; Lye, David C.
Afiliación
  • Lee IR; National Centre for Infectious Diseases, Singapore, Singapore. ivor_russel_mc_lee@ncid.sg.
  • Tong SYC; Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Davis JS; School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
  • Paterson DL; University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital Campus, Brisbane, Australia.
  • Syed-Omar SF; University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Peck KR; Samsung Medical Center, Seoul, South Korea.
  • Chung DR; Samsung Medical Center, Seoul, South Korea.
  • Cooke GS; Department of Infectious Diseases, Imperial College London, London, UK.
  • Libau EA; National Centre for Infectious Diseases, Singapore, Singapore.
  • Rahman SBA; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.
  • Gandhi MP; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.
  • Shi L; Singapore Clinical Research Institute, Consortium for Clinical Research and Innovation, Singapore, Singapore.
  • Zheng S; Department of Infectious Disease, Sengkang General Hospital, Singapore, Singapore.
  • Chaung J; Division of Infectious Diseases, Ng Teng Fong General Hospital, Singapore, Singapore.
  • Tan SY; Department of Infectious Diseases, Changi General Hospital, Singapore, Singapore.
  • Kalimuddin S; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
  • Archuleta S; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
  • Lye DC; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.
Trials ; 23(1): 572, 2022 Jul 19.
Article en En | MEDLINE | ID: mdl-35854360
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Bacteriemia Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Límite: Adult / Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Bacteriemia Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research Límite: Adult / Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur